DiscoverIQ Insigniam Quarterly® AudibleNeil Archer Leads Bristol Myers Squibb Acquisition Through Disruption
Neil Archer Leads Bristol Myers Squibb Acquisition Through Disruption

Neil Archer Leads Bristol Myers Squibb Acquisition Through Disruption

Update: 2022-07-19
Share

Description

In 2019, Bristol-Myers Squibb Company and Celgene Corporation announced to the world that they had entered into a definitive acquisition agreement. Bristol-Myers Squibb would acquire Celgene in a cash and stock transaction with an equity value of approximately $74 billion. It was the largest pharmaceutical acquisition in history.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Neil Archer Leads Bristol Myers Squibb Acquisition Through Disruption

Neil Archer Leads Bristol Myers Squibb Acquisition Through Disruption

Insigniam